MADELINE OLSON: Open Payments
NPI 1184485583 · PAPILLION, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$767 in 34 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $491 · 2025 $767
Food & beverage: $767
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $210 |
| AstraZeneca Pharmaceuticals LP | 6 | $148 |
| Corcept Therapeutics | 1 | $120 |
| Lilly USA, LLC | 4 | $82 |
| Novo Nordisk Inc | 3 | $60 |
| PFIZER INC. | 3 | $53 |
| Astellas Pharma US Inc | 1 | $47 |
| Hologic Sales and Service, LLC | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $14 |
| Exact Sciences Corporation | 1 | $14 |
Products named: Korlym, QULIPTA, MOUNJARO, VRAYLAR, UBRELVY, Veozah, Wegovy, PAXLOVID.
Industry payments across NE — which companies pay providers there.
